{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:34:14Z","timestamp":1783496054878,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T00:00:00Z","timestamp":1567209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ekir.2019.08.019","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T11:31:28Z","timestamp":1568028688000},"page":"1608-1616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Steroid-Associated Side Effects in Patients With Primary Proteinuric Kidney Disease"],"prefix":"10.1016","volume":"4","author":[{"given":"Gia J.","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Waldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Paez-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick E.","family":"Gipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pesenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Selewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Kamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan F.","family":"Massengill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Lafayette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg","family":"Modes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon G.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailey","family":"Desmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Eikstadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samara","family":"Attalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubin J.","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Troost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie S.","family":"Gipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2019.08.019_bib1","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/rheumatology\/keu148","article-title":"Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus","volume":"53","author":"Ruiz-Arruza","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.ekir.2019.08.019_bib2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2796.1994.tb00855.x","article-title":"Corticosteroids and peptic ulcer:meta-analysis of adverse events during steroid therapy","volume":"236","author":"Conn","year":"1994","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.ekir.2019.08.019_bib3","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s40265-014-0282-9","article-title":"Systemic glucocorticoid therapy:a review of its metabolic and cardiovascular adverse events","volume":"74","author":"Fardet","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.ekir.2019.08.019_bib4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/art.39537","article-title":"Risk of incident diabetes mellitus associated with the dosage and duration of oral glucocorticoid therapy in patients with rheumatoid arthritis","volume":"68","author":"Movahedi","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ekir.2019.08.019_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ekir.2017.11.016","article-title":"NephCure Accelerating Cures Institute: a multidisciplinary consortium to improve care for nephrotic syndrome","volume":"3","author":"Gipson","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2019.08.019_bib6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/dc18-Sint01","article-title":"Introduction: standards of medical care in diabetes\u20142018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ekir.2019.08.019_bib7","unstructured":"The University of Michigan Department of Pathology. Clinical Test Catalog. Available at: https:\/\/pathology.med.umich.edu\/handbook\/. Accessed July 1, 2018."},{"key":"10.1016\/j.ekir.2019.08.019_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cct.2016.01.010","article-title":"Design, development and deployment of a Diabetes Research Registry to facilitate recruitment in clinical research","volume":"47","author":"Tan","year":"2016","journal-title":"Contemp Clin Trials"},{"issue":"6(suppl 2)","key":"10.1016\/j.ekir.2019.08.019_bib9","first-page":"51S","article-title":"evaluation, and\u00a0treatment of\u00a0overweight and\u00a0obesity in\u00a0adults\u2014the\u00a0evidence\u00a0report. National Institutes of Health","year":"1998","journal-title":"Obes Res"},{"issue":"120(suppl 4)","key":"10.1016\/j.ekir.2019.08.019_bib10","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1542\/peds.2007-2329C","article-title":"Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report","author":"Barlow","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.ekir.2019.08.019_bib11","first-page":"43","article-title":"Evaluation of short and tall stature in children","volume":"92","author":"Barstow","year":"2015","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ekir.2019.08.019_bib12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2019.08.019_bib13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ekir.2019.08.019_bib14","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1681\/ASN.2011111112","article-title":"Corticosteroid therapy in IgA nephropathy","volume":"23","author":"Lv","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2019.08.019_bib15","doi-asserted-by":"crossref","first-page":"c54","DOI":"10.1159\/000097598","article-title":"Glucocorticoid-induced diabetes mellitus:prevalence and risk factors in primary renal diseases","volume":"105","author":"Uzu","year":"2007","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.ekir.2019.08.019_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/TP.0b013e318203c25f","article-title":"New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression","volume":"91","author":"Luan","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2019.08.019_bib17","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","article-title":"Intensive supportive care plus immunosuppression in IgA nephropathy","volume":"373","author":"Rauen","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2019.08.019_bib18","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2017.9362","article-title":"Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial","volume":"318","author":"Lv","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2019.08.019_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00431-009-0989-x","article-title":"Primary peritonitis in children with nephrotic syndrome: results of a 5-year multicenter study","volume":"169","author":"Uncu","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ekir.2019.08.019_bib20","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archpedi.1982.03970440076023","article-title":"Peritonitis in childhood nephrotic syndrome: 1970\u20131980","volume":"136","author":"Krensky","year":"1982","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.ekir.2019.08.019_bib21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"Van Staa","year":"2000","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ekir.2019.08.019_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pds.1075","article-title":"The population risk of fractures attributable to oral corticosteroids","volume":"14","author":"Donnan","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ekir.2019.08.019_bib23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.5414\/CP202732","article-title":"A\u00a0case of multiple vertebral compression fractures due to glucocorticoid-induced osteoporosis in a pediatric patient with nephrotic syndrome","volume":"55","author":"Ashida","year":"2017","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.ekir.2019.08.019_bib24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00467-010-1652-5","article-title":"Vertebral fractures despite normal spine bone mineral density in a boy with nephrotic syndrome","volume":"26","author":"Sbrocchi","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2019.08.019_bib25","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/archinte.167.13.1379","article-title":"Albuminuria and risk of nonvertebral fractures","volume":"167","author":"Jorgensen","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ekir.2019.08.019_bib26","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2215\/CJN.09500916","article-title":"Fractures in patients with CKD: time for action","volume":"11","author":"Moe","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2019.08.019_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2215\/CJN.06640712","article-title":"Albuminuria and rapid loss of GFR and risk of new hip and pelvic fractures","volume":"8","author":"Barzilay","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2019.08.019_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1749-6632.2009.04981.x","article-title":"Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy","volume":"1179","author":"Brown","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ekir.2019.08.019_bib29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00467-015-3216-1","article-title":"Behavioural abnormalities in children with new-onset nephrotic syndrome receiving corticosteroid therapy: results of a prospective longitudinal study","volume":"31","author":"Upadhyay","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2019.08.019_bib30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1017\/S1355617712001014","article-title":"Acute cognitive and behavioral effects of systemic corticosteroids in children treated for inflammatory bowel disease","volume":"19","author":"Mrakotsky","year":"2013","journal-title":"J\u00a0Int Neuropsychol Soc"},{"key":"10.1016\/j.ekir.2019.08.019_bib31","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s12098-014-1338-2","article-title":"Ocular complications in children with nephrotic syndrome on long term oral steroids","volume":"81","author":"Gaur","year":"2014","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.ekir.2019.08.019_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1442-9071.2001.00426.x","article-title":"Ocular complications of paediatric patients with nephrotic syndrome","volume":"29","author":"Ng","year":"2001","journal-title":"Clin Exp Ophthalmol"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024919314755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024919314755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:25:40Z","timestamp":1762831540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024919314755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S2468024919314755"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2019.08.019","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Steroid-Associated Side Effects in Patients With Primary Proteinuric Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2019.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}